Hong Kong Drug Office has published some guidelines on the recall of pharmaceutical products in March 2022.
Pharmaceutical products are subjected to a recall when there is suspicion on the potential
Regulatory News
Singapore HSA Announces Requirement for Notification of Lot Release Information of Imported Vaccines
The Health Sciences Authority (HSA) Singapore has published an update regarding the notification of lot release information of imported registered vaccines before they are supplied to Singapore, and this information
Australia TGA Publishes Latest Guidance on Reclassification of Active Implantable Medical Devices
The Therapeutic Goods Administration (TGA) Australia has published the latest document on the reclassification of active implantable medical devices (AIMD) with information on transitional arrangements and obligations, in March 2022.
Active
NPRA Malaysia Publishes Frequently Asked Questions on Medicinal Gases
National Pharmaceutical Regulatory Agency (NPRA) Malaysia has issued a set of frequently asked questions (FAQs) on medicinal gases in February 2022.
The document provides detailed information on the questions and answers
Singapore HSA Publishes Guidelines on Voluntary Electronic Labelling for Complementary Health Products
The Health Sciences Authority (HSA) Singapore has published a guidance document on voluntary electronic labelling for complementary health products (CHP) in March 2022.
Electronic labelling, also known as e-labelling, is information
Hong Kong Drug Office Publishes Guidance Notes on Registration of Pharmaceutical Products
Hong Kong Drug Office has published some guidance notes on the requirements of pharmaceutical products in February 2022.
Registration of pharmaceutical products needs to be completed before being sold in Hong
Singapore HSA Publishes Revised Guidance on Health Supplements Guidelines
The Health Sciences Authority (HSA) Singapore has published the latest guidance document on health supplements in March 2022.
The working definition of health supplements has been updated to be in accordance
Australia TGA Publishes Information on Regulation Essentials
The Therapeutic Goods Administration (TGA) Australia has published a general overview of the regulatory process, along with information about relevant resources.
The TGA is involved with the regulation of therapeutic goods
Hong Kong Drug Office Publishes Information on Requirement of Elemental Impurities Levels or Limits
Hong Kong Drug Office has published a guideline on the requirement of elemental impurities levels or limits in registered pharmaceutical products in February 2022.
As stipulated in the International Council for